切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2017, Vol. 06 ›› Issue (02) : 81 -84. doi: 10.3877/cma.j.issn.2095-3232.2017.02.002

所属专题: 综述 文献

述评

肝门部胆管癌手术治疗的热点与难点
殷晓煜1,()   
  1. 1. 510080 广州,中山大学附属第一医院胆胰外科
  • 收稿日期:2016-12-20 出版日期:2017-04-10
  • 通信作者: 殷晓煜
  • 基金资助:
    广东省自然科学基金(2015A030313032)

Highlight and difficulty of surgical treatment for hilar cholangiocarcinoma

Xiaoyu Yin1()   

  • Received:2016-12-20 Published:2017-04-10
  • Corresponding author: Xiaoyu Yin
引用本文:

殷晓煜. 肝门部胆管癌手术治疗的热点与难点[J/OL]. 中华肝脏外科手术学电子杂志, 2017, 06(02): 81-84.

Xiaoyu Yin. Highlight and difficulty of surgical treatment for hilar cholangiocarcinoma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2017, 06(02): 81-84.

[1]
DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution[J]. Ann Surg, 2007, 245(5):755-762.
[2]
Rizvi S, Gores GJ. Pathogenesis, diagnosis and management of cholangiocarcinoma[J]. Gastroenterology, 2013, 145(6):1215-1229.
[3]
中国抗癌协会.肝门部胆管癌规范化诊治专家共识(2015)[J]. 中华肝胆外科杂志,2015,21(8):505-511.
[4]
Mansour JC, Aloia TA, Crane CH, et al. Hilar cholangiocarcinoma: expert consensus statement[J]. HPB, 2015, 17(8):691-699.
[5]
Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections[J]. Ann Surg, 2013, 258(1):129-140.
[6]
殷晓煜,刘鑫,陈伟,等.肝门部胆管癌手术切除的远期疗效及预后因素分析[J].中华消化外科杂志,2016,15(4):329-333.
[7]
Ruys AT, van Beem BE, Engelbrecht MR, et al. Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis[J]. Br J Radiol, 2012, 85(1017):1255-1262.
[8]
Vilgrain V. Staging cholangiocarcinoma by imaging studies[J]. HPB, 2008, 10(2):106-109.
[9]
Lee HY, Kim SH, Lee JM, et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria[J]. Radiology, 2006, 239(1):113-121.
[10]
Masselli G, Manfredi R, Vecchioli A, et al. MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings[J]. Eur Radiol, 2008, 18(10):2213-2221.
[11]
Chryssou E, Guthrie JA, Ward J, et al. Hilar cholangiocarcinoma: MR correlation with surgical and histological findings[J]. Clin Radiol, 2010, 65(10):781-788.
[12]
Hänninen EL, Pech M, Jonas S, et al. Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions[J]. Acta Radiol, 2005, 46(5):462-470.
[13]
Farges O, Regimbeau JM, Fuks D, et al. Multicentre european study of preoperative biliary drainage for hilar cholangiocarcinoma[J]. Br J Surg, 2013, 100(2):274-283.
[14]
Kennedy TJ, Yopp A, Qin Y, et al. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma[J]. HPB, 2009, 11(5):445-451.
[15]
Kawakami H, Kuwatani M, Onodera M, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma[J]. J Gastroenterol, 2011, 46(2):242-248.
[16]
El-Hanafy E. Pre-operative biliary drainage in hilar cholangiocarcinoma, benefits and risks, single center experience[J]. Hepatogastroenterology, 2010, 57(99/100):414-419.
[17]
Takahashi Y, Nagino M, Nishio H, et al. Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma[J]. Br J Surg, 2010, 97(12):1860-1866.
[18]
张学文,杨永生,张博开.术前减黄在胆道肿瘤治疗中的应用[J/CD].中华肝脏外科手术学电子杂志,2015,4(2):69-72.
[19]
Hemming AW, Mekeel K, Khanna A, et al. Portal vein resection in management of hilar cholangiocarcinoma[J]. J Am Coll Surg, 2011, 212(4):604-613.
[20]
Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases[J]. Ann Surg, 2003, 238(5):720-727.
[21]
Liang G, Wen T, Mi K, et al. Resection of hilar cholangiocarcinoma combined with left hepatectomy and common hepatic arteriectomy without reconstruction[J]. Hepatogastroenterology, 2012, 59(114):364-365.
[22]
Qiu J, Wu H, Prasoon P, et al. Portal vein arterialization in hilar cholangiocarcinoma: one case report and literature review[J]. Eur J Gastroenterol Hepatol, 2012, 24(3):229-232.
[1] 郝玥萦, 毛盈譞, 张羽, 汪佳旭, 韩林霖, 匡雯雯, 孟瑶, 杨秀华. 超声引导衰减参数成像评估肝脂肪变性及其对心血管疾病风险的预测价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 770-777.
[2] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[5] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[6] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[7] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[8] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[9] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-144.
[10] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
[11] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[12] 广东省护士协会介入护士分会, 广东省医师协会介入医师分会. 原发性肝癌低血糖患者护理规范管理专家共识[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 709-714.
[13] 韦巧玲, 黄妍, 赵昌, 宋庆峰, 陈祖毅, 黄莹, 蒙嫦, 黄靖. 肝癌微波消融术后中重度疼痛风险预测列线图模型构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 715-721.
[14] 蔡晓雯, 李慧景, 丘婕, 杨翼帆, 吴素贤, 林玉彤, 何秋娜. 肝癌患者肝动脉化疗栓塞术后疼痛风险预测模型的构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 722-728.
[15] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?